Skip to content

Trial Summary

This study aims to show that brain metastases from Human Epidermal Growth Factor Receptor Type 2 (HER2) positive breast cancers are able to be controlled by local therapies, Stereotactic Radiosurgery (SRS) and/or Neurosurgery (NS).

Acronym:

Local HER-O

ACTRN/NCT /ethics:

NCT02898727

Scientific title:

A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer

Sponsor / Cooperative group:

TROG Cancer Research

Trial & Patient Characteristics

Cancer TypeBreast
Trial TypeTreatment
PhasePhase II
Age Range18 years and older
SexBoth
Tumour Stream -
Cancer StageMetastatic or Widespread
Anticipated Start Date2017-11-20
Anticipated End Date2020-05-01

Participating Hospitals

HospitalRoyal Adelaide Hospital
Clinical Trial CoordinatorAnne Milton
Emailanne.milton@sa.gov.au
Phone08 7074 2342
Principal InvestigatorProfessor Hui Tee
Recruitment StatusRecruiting